What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Buy
56
PRTC Quote, Financials, Valuation and Earnings
Last price:
$16.91
Seasonality move
:
4.13%
Day range:
$16.91 - $16.91
52-week range:
$13.30 - $23.35
Dividend yield:
0%
P/E ratio:
9.57x
P/S ratio:
66.19x
P/B ratio:
1.02x
Volume:
481
Avg. volume:
3.9K
1-year change:
-19.17%
Market cap:
$408.1M
Revenue:
$4.8M
EPS (TTM):
$1.65
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PRTC
PureTech Health Plc
|
-- | -- | -- | -- | $46.00 |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
NNVC
NanoViricides, Inc.
|
-- | -$0.20 | -- | -26.67% | $7.00 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.38 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PRTC
PureTech Health Plc
|
$16.91 | $46.00 | $408.1M | 9.57x | $0.00 | 0% | 66.19x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$2.80 | $0.85 | $352.8M | 4.70x | $0.80 | 0% | 5.44x |
|
NNVC
NanoViricides, Inc.
|
$1.25 | $7.00 | $22.5M | -- | $0.00 | 0% | -- |
|
OGEN
Oragenics, Inc.
|
$0.91 | $2.00 | $752.1K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TOVX
Theriva Biologics, Inc.
|
$0.22 | $7.00 | $7.3M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PRTC
PureTech Health Plc
|
-- | 0.525 | -- | -- |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | 2.113 | 8.08% | 1.85x |
|
NNVC
NanoViricides, Inc.
|
-- | 0.464 | -- | 0.95x |
|
OGEN
Oragenics, Inc.
|
3.86% | -0.075 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -3.365 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PRTC
PureTech Health Plc
|
-- | -- | -- | -- | -- | -- |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
NNVC
NanoViricides, Inc.
|
-$132.8K | -$1.8M | -92.29% | -92.29% | -- | -$1.7M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
PureTech Health Plc vs. Competitors
-
Which has Higher Returns PRTC or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -- compared to PureTech Health Plc's net margin of -255.85%. PureTech Health Plc's return on equity of -- beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital PRTCPureTech Health Plc-- -- -- NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About PRTC or NBY?
PureTech Health Plc has a consensus price target of $46.00, signalling upside risk potential of 172.03%. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -69.64%. Given that PureTech Health Plc has higher upside potential than NovaBay Pharmaceuticals, Inc., analysts believe PureTech Health Plc is more attractive than NovaBay Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PRTCPureTech Health Plc1 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is PRTC or NBY More Risky?
PureTech Health Plc has a beta of 1.127, which suggesting that the stock is 12.69% more volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.103%.
-
Which is a Better Dividend Stock PRTC or NBY?
PureTech Health Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. PureTech Health Plc pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRTC or NBY?
PureTech Health Plc quarterly revenues are --, which are smaller than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. PureTech Health Plc's net income of -- is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, PureTech Health Plc's price-to-earnings ratio is 9.57x while NovaBay Pharmaceuticals, Inc.'s PE ratio is 4.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PureTech Health Plc is 66.19x versus 5.44x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRTCPureTech Health Plc66.19x 9.57x -- -- NBYNovaBay Pharmaceuticals, Inc.5.44x 4.70x $521K -$1.3M
-
Which has Higher Returns PRTC or NNVC?
NanoViricides, Inc. has a net margin of -- compared to PureTech Health Plc's net margin of --. PureTech Health Plc's return on equity of -- beat NanoViricides, Inc.'s return on equity of -92.29%.
Company Gross Margin Earnings Per Share Invested Capital PRTCPureTech Health Plc-- -- -- NNVCNanoViricides, Inc.-- -$0.10 $7.2M -
What do Analysts Say About PRTC or NNVC?
PureTech Health Plc has a consensus price target of $46.00, signalling upside risk potential of 172.03%. On the other hand NanoViricides, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 460%. Given that NanoViricides, Inc. has higher upside potential than PureTech Health Plc, analysts believe NanoViricides, Inc. is more attractive than PureTech Health Plc.
Company Buy Ratings Hold Ratings Sell Ratings PRTCPureTech Health Plc1 0 0 NNVCNanoViricides, Inc.0 0 0 -
Is PRTC or NNVC More Risky?
PureTech Health Plc has a beta of 1.127, which suggesting that the stock is 12.69% more volatile than S&P 500. In comparison NanoViricides, Inc. has a beta of 1.158, suggesting its more volatile than the S&P 500 by 15.816%.
-
Which is a Better Dividend Stock PRTC or NNVC?
PureTech Health Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NanoViricides, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PureTech Health Plc pays -- of its earnings as a dividend. NanoViricides, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRTC or NNVC?
PureTech Health Plc quarterly revenues are --, which are smaller than NanoViricides, Inc. quarterly revenues of --. PureTech Health Plc's net income of -- is lower than NanoViricides, Inc.'s net income of -$1.8M. Notably, PureTech Health Plc's price-to-earnings ratio is 9.57x while NanoViricides, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PureTech Health Plc is 66.19x versus -- for NanoViricides, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRTCPureTech Health Plc66.19x 9.57x -- -- NNVCNanoViricides, Inc.-- -- -- -$1.8M
-
Which has Higher Returns PRTC or OGEN?
Oragenics, Inc. has a net margin of -- compared to PureTech Health Plc's net margin of --. PureTech Health Plc's return on equity of -- beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital PRTCPureTech Health Plc-- -- -- OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About PRTC or OGEN?
PureTech Health Plc has a consensus price target of $46.00, signalling upside risk potential of 172.03%. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 118.82%. Given that PureTech Health Plc has higher upside potential than Oragenics, Inc., analysts believe PureTech Health Plc is more attractive than Oragenics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PRTCPureTech Health Plc1 0 0 OGENOragenics, Inc.1 0 0 -
Is PRTC or OGEN More Risky?
PureTech Health Plc has a beta of 1.127, which suggesting that the stock is 12.69% more volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.781%.
-
Which is a Better Dividend Stock PRTC or OGEN?
PureTech Health Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PureTech Health Plc pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRTC or OGEN?
PureTech Health Plc quarterly revenues are --, which are smaller than Oragenics, Inc. quarterly revenues of --. PureTech Health Plc's net income of -- is lower than Oragenics, Inc.'s net income of -$3.1M. Notably, PureTech Health Plc's price-to-earnings ratio is 9.57x while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PureTech Health Plc is 66.19x versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRTCPureTech Health Plc66.19x 9.57x -- -- OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns PRTC or PTN?
Palatin Technologies has a net margin of -- compared to PureTech Health Plc's net margin of --. PureTech Health Plc's return on equity of -- beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PRTCPureTech Health Plc-- -- -- PTNPalatin Technologies-- -- -- -
What do Analysts Say About PRTC or PTN?
PureTech Health Plc has a consensus price target of $46.00, signalling upside risk potential of 172.03%. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than PureTech Health Plc, analysts believe Palatin Technologies is more attractive than PureTech Health Plc.
Company Buy Ratings Hold Ratings Sell Ratings PRTCPureTech Health Plc1 0 0 PTNPalatin Technologies0 0 0 -
Is PRTC or PTN More Risky?
PureTech Health Plc has a beta of 1.127, which suggesting that the stock is 12.69% more volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock PRTC or PTN?
PureTech Health Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PureTech Health Plc pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRTC or PTN?
PureTech Health Plc quarterly revenues are --, which are smaller than Palatin Technologies quarterly revenues of --. PureTech Health Plc's net income of -- is lower than Palatin Technologies's net income of --. Notably, PureTech Health Plc's price-to-earnings ratio is 9.57x while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PureTech Health Plc is 66.19x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRTCPureTech Health Plc66.19x 9.57x -- -- PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns PRTC or TOVX?
Theriva Biologics, Inc. has a net margin of -- compared to PureTech Health Plc's net margin of --. PureTech Health Plc's return on equity of -- beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital PRTCPureTech Health Plc-- -- -- TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About PRTC or TOVX?
PureTech Health Plc has a consensus price target of $46.00, signalling upside risk potential of 172.03%. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 3121.35%. Given that Theriva Biologics, Inc. has higher upside potential than PureTech Health Plc, analysts believe Theriva Biologics, Inc. is more attractive than PureTech Health Plc.
Company Buy Ratings Hold Ratings Sell Ratings PRTCPureTech Health Plc1 0 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is PRTC or TOVX More Risky?
PureTech Health Plc has a beta of 1.127, which suggesting that the stock is 12.69% more volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.818%.
-
Which is a Better Dividend Stock PRTC or TOVX?
PureTech Health Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PureTech Health Plc pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRTC or TOVX?
PureTech Health Plc quarterly revenues are --, which are smaller than Theriva Biologics, Inc. quarterly revenues of --. PureTech Health Plc's net income of -- is lower than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, PureTech Health Plc's price-to-earnings ratio is 9.57x while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PureTech Health Plc is 66.19x versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRTCPureTech Health Plc66.19x 9.57x -- -- TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Is JetBlue The Best Airline Stock?
Following a general trend of improvement among airline stocks, shares…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
73
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 39x
Alerts
Buy
80
FEIM alert for Dec 15
Frequency Electronics, Inc. [FEIM] is down 7.36% over the past day.
Buy
57
MOD alert for Dec 15
Modine Manufacturing Co. [MOD] is up 1.49% over the past day.
Sell
42
OKLO alert for Dec 15
Oklo, Inc. [OKLO] is down 3.96% over the past day.
